ERBB2 and neoplasm: Unfortunately, we could not analyze tumor tissue prior to Her2-directed treatment and compare the results of the expression analysis with response, since gastroesophageal adenocarcinoma patients are currently only treated in a metastatic setting outside of clinical trials.